News & Perspective

Nov 05, 2008

Nov 05, 2008

Study: Media can distort public's views on infectious diseases

(CIDRAP News) – Media coverage of infectious diseases such as avian influenza can create the impression that the conditions are more of a threat than they really are, according to a recent study from Canada.

Sep 10, 2007

Sep 10, 2007

Chikungunya fever gains foothold in Europe

(CIDRAP News) – A recent outbreak of the debilitating tropical disease known as chikungunya fever in northern Italy apparently marks the mosquito-borne infection's first foothold in Europe, according to European health authorities.

May 02, 2006

May 02, 2006

West Nile vaccine induces good response in human trial

(CIDRAP News) – The first published report of a phase 1 clinical trial of a West Nile virus vaccine shows promise, with 41 of 42 inoculated volunteers (98%) developing antibodies to the virus.

May 11, 2005

May 11, 2005

West Nile vaccine looks good in early human trial

(CIDRAP News) – An initial human trial of a West Nile virus (WNV) vaccine has yielded promising results, officials said today.

In the double-blind, randomized trial, all but one of the people who received the vaccine developed antibodies to it, according to an Associated Press (AP) report quoting Dr. Thomas Monath, chief scientist at Acambis, the company that created the vaccine.

Mar 22, 2005

Mar 22, 2005

Mysterious hemorrhagic fever in Angola has killed 39

(CIDRAP News) – An unidentified hemorrhagic fever appears to be targeting children younger than 5 in an outbreak in the African country of Angola.

At least 39 people are believed to have died of the suspected hemorrhagic fever syndrome in the northern province of Uige between January and mid-March, the World Health Organization (WHO) announced on Mar 17.

Nov 07, 2003

Nov 07, 2003

Acambis launches clinical trial of West Nile vaccine

(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.

The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»